Tech Company Financing Transactions
Novalar Pharmaceuticals Funding Round
Novalar Pharmaceuticals secured a $27 million Series C funding round on 3/11/2005. Backers included Boston Millennia Partners, Domain Associates and Montreux Equity Partners.
Transaction Overview
Company Name
Announced On
3/11/2005
Transaction Type
Venture Equity
Amount
$27,000,000
Round
Series C
Proceeds Purpose
This financing will be used to support pivotal clinical trials and the commercial launch of NV-101.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
12555 High Bluff Drive 300
San Diego, CA 92130
USA
San Diego, CA 92130
USA
Phone
Website
Email Address
Overview
Novalar Pharmaceuticals, Inc. is a privately-held specialty pharmaceutical company based in San Diego, California.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Donna Janson
Chief Financial Officer
Robert Stefanovich
Chief Medical Officer
Richard Ghalie
Chief Operating Officer
Laura Navalta
Vice President
Doug Bakan
VP - Sales
Jeffrey Lord
Browse more venture capital transactions:
Prev: 3/10/2005: Alantos Pharmaceuticals Holding venture capital transaction
Next: 3/11/2005: LoyaltyLab venture capital transaction
Share this article
About Our VC Transactions Data
We report on every notable VC transaction. All VC database entries reported here are derived from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs